28On 13 December 2023, the Commission adopted Implementing Decision C(2023) 8920 final, revoking Decision C(2022) 3252 (final) granting marketing authorisation for the medicinal product for human use ‘Dimethyl fumarate Mylan – dimethyl fumarate’ (see paragraph 25 above). Implementing Decision C(2023) 8920 final was the subject of an action for annulment brought by the applicant before the General Court on 22 December 2023, registered under case number T‑1182/23. That action is still pending.